Computer-Based Cognitive Behavioral Therapy for Chronic Pain in Opioid Treatment
(IMPACT Trial)
Trial Summary
What is the purpose of this trial?
The investigators plan to develop and pilot test an integrated, web-based cognitive behavioral approach and then conduct a randomized clinical trial evaluating its efficacy relative to standard care in a large and diverse sample of individuals with chronic pain treated with buprenorphine or methadone. The new program will retain key components of Dr. Carroll's computer-based training for cognitive-behavioral therapy (CBT4CBT), including its emphasis on teaching cognitive and behavioral coping skills in an engaging way and focus on the 5 A's of MAT (Adherence, Attendance, Abstinence, Alternate Activities and Accessing support); it will add components from Dr. Heapy's COPES (Cooperative Pain Education and Self-Management) intervention (self-management of chronic pain, with daily surveys via text that monitor pain intensity and interference, physical activity, and skills practice) and modify existing CBT4CBT modules to address the complex interplay between pain and drug use in this population, emphasizing the development of generalizable skills. A randomized clinical trial evaluating CBT4CBT-COPES will be conducted in a diverse sample 160 of individuals enrolled in agonist treatment (methadone or buprenorphine) who have chronic pain, in a 3-month randomized clinical trial with a 6-month follow-up, comparing it to standard treatment alone. The primary retention outcome will be adherence with agonist treatment; the primary pain outcome will be the PROMIS 6-item Pain Interference Short Form.
Do I have to stop taking my current medications to join the trial?
The trial does not specify if you need to stop taking your current medications. However, participants must be enrolled in methadone or buprenorphine treatment, so you should continue those medications.
Will I have to stop taking my current medications?
The trial does not specify if you need to stop taking your current medications. However, it does require participants to be on methadone or buprenorphine treatment.
What data supports the idea that Computer-Based Cognitive Behavioral Therapy for Chronic Pain in Opioid Treatment is an effective treatment?
The available research shows that Computer-Based Cognitive Behavioral Therapy (CBT) for chronic pain is effective. Studies indicate that CBT helps people manage chronic pain and improve their outcomes. For example, the COPES trial found that technology-assisted CBT is as effective as in-person therapy for chronic back pain. Additionally, web-based CBT has been shown to increase access to pain management and is comparable in effectiveness to face-to-face therapy. These findings suggest that computer-based CBT is a promising alternative for those who cannot access traditional therapy.12345
What data supports the effectiveness of the treatment CBT4CBT COPES for chronic pain in opioid treatment?
Cognitive behavioral therapy (CBT) has been shown to help manage chronic pain and improve outcomes, and technology-assisted delivery of CBT can maintain its effectiveness while improving access. Studies have found that web-based CBT can be as effective as in-person therapy for chronic pain management.12345
What safety data exists for computer-based CBT for chronic pain?
The research indicates that cognitive behavioral therapy for chronic pain (CBT-CP) is a safe and effective alternative to opioid analgesics. Multiple studies have shown that CBT-CP is an evidence-based treatment that improves pain management and outcomes. Technology-assisted delivery of CBT, such as through interactive voice response or web-based platforms, can maintain efficacy while improving access, although specific safety data for these formats is not detailed in the provided abstracts.12346
Is computer-based cognitive behavioral therapy for chronic pain safe for humans?
Is the treatment CBT4CBT COPES a promising treatment for chronic pain in people using opioids?
Yes, CBT4CBT COPES is a promising treatment for chronic pain. It is based on cognitive-behavioral therapy, which has been shown to be effective in reducing pain and related problems. This type of therapy can be delivered through technology, making it more accessible to people who might not have easy access to therapists. It is a safe alternative to using opioids for pain management.23678
How is the CBT4CBT COPES treatment different from other treatments for chronic pain?
Research Team
Alicia Heapy, PhD
Principal Investigator
Yale University
Eligibility Criteria
Adults over 18 with opioid use disorder (OUD) who are on methadone or buprenorphine treatment and have chronic pain. They must be able to walk a block, speak English at a basic level, and not have severe health issues or untreated mental disorders that could interfere with the study.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive CBT4CBT-COPES or standard care for 12 weeks, with weekly meetings and assessments
Follow-up
Participants are monitored for safety and effectiveness after treatment, with follow-up interviews at 1, 3, and 6 months post-treatment
Treatment Details
Interventions
- CBT4CBT COPES
CBT4CBT COPES is already approved in United States for the following indications:
- Chronic pain management in individuals treated with buprenorphine or methadone
Find a Clinic Near You
Who Is Running the Clinical Trial?
Yale University
Lead Sponsor
National Center for Complementary and Integrative Health (NCCIH)
Collaborator
National Institutes of Health (NIH)
Collaborator